|
US3622666A
(en)
*
|
1968-03-04 |
1971-11-23 |
Stanley Drug Products Inc |
Methods for treating bacterial infections with phrenosin
|
|
FR2492259A1
(fr)
|
1980-10-21 |
1982-04-23 |
Idinvex Sa |
Formulation d'heparine
|
|
JPS61152632A
(ja)
|
1984-12-26 |
1986-07-11 |
Dai Ichi Seiyaku Co Ltd |
抗動脈硬化剤
|
|
JPS6344842A
(ja)
|
1986-08-12 |
1988-02-25 |
Kao Corp |
油中水中油型乳化油脂組成物
|
|
IT1235162B
(it)
|
1988-12-02 |
1992-06-22 |
Fidia Farmaceutici |
Derivati di lisosfingolipidi
|
|
US5190876A
(en)
|
1988-12-27 |
1993-03-02 |
Emory University |
Method of modifying cellular differentiation and function and compositions therefor
|
|
JPH05508863A
(ja)
|
1990-08-13 |
1993-12-09 |
デューク・ユニバーシティ |
セラミドを使用して細胞分裂を誘導する方法
|
|
US5543390A
(en)
*
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
Covalent microparticle-drug conjugates for biological targeting
|
|
US5232837A
(en)
|
1991-08-05 |
1993-08-03 |
Emory University |
Method of altering sphingolipid metabolism and detecting fumonisin ingestion and contamination
|
|
US5374616A
(en)
|
1991-10-18 |
1994-12-20 |
Georgetown University |
Compositions containing sphingosylphosphorylcholine and the use thereof as a cellular growth factor
|
|
JPH05320048A
(ja)
*
|
1992-05-19 |
1993-12-03 |
Shiseido Co Ltd |
抗酸化剤
|
|
US6190894B1
(en)
|
1993-03-19 |
2001-02-20 |
The Regents Of The University Of California |
Method and compositions for disrupting the epithelial barrier function
|
|
US5478860A
(en)
|
1993-06-04 |
1995-12-26 |
Inex Pharmaceuticals Corp. |
Stable microemulsions for hydrophobic compound delivery
|
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
|
US6773719B2
(en)
|
1994-03-04 |
2004-08-10 |
Esperion Luv Development, Inc. |
Liposomal compositions, and methods of using liposomal compositions to treat dislipidemias
|
|
US20020182250A1
(en)
|
1995-09-06 |
2002-12-05 |
Goro Hori |
Lipid metabolism improving agent
|
|
WO1997011706A1
(en)
|
1995-09-29 |
1997-04-03 |
Georgetown University |
Use of sphingosylphosphorylcholine as a wound-healing agent
|
|
DE19602108A1
(de)
*
|
1996-01-22 |
1997-07-24 |
Beiersdorf Ag |
Gegen Bakterien, Parasiten, Protozoen, Mycota und Viren wirksame Substanzen
|
|
AU2195297A
(en)
|
1996-02-20 |
1997-09-02 |
Sloan-Kettering Institute For Cancer Research |
Combinations of pkc inhibitors and therapeutic agents for treating cancers
|
|
JP4545235B2
(ja)
|
1996-03-28 |
2010-09-15 |
ディーエスエム アイピー アセッツ ビー．ブイ． |
顆粒状微生物バイオマスの製造法とそのバイオマスからの貴重化合物の単離法
|
|
ATE286735T1
(de)
|
1997-04-10 |
2005-01-15 |
Kirin Brewery |
Verwendung von a-glycosylceramiden zur herstellung eines therapeutischen mittelszur behandlung von autoimmunkrankheiten
|
|
US6800661B1
(en)
|
1997-04-15 |
2004-10-05 |
Board Of Trustees Of The University Of Illinois |
Spisulosine compounds
|
|
ES2210767T3
(es)
|
1997-05-02 |
2004-07-01 |
Cosmoferm B.V. |
Composiciones antimicrobianas para uso topico.
|
|
US5989803A
(en)
|
1997-09-05 |
1999-11-23 |
The Trustees Of Columbia University In The City Of New York |
Method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase
|
|
WO1999012890A1
(fr)
*
|
1997-09-11 |
1999-03-18 |
Takara Shuzo Co., Ltd. |
Derives de sphingosine et composition medicamenteuse
|
|
EP1053243B1
(en)
*
|
1998-02-12 |
2011-03-30 |
Emory University |
Sphingolipid derivatives and their methods of use
|
|
JP3581010B2
(ja)
|
1998-03-18 |
2004-10-27 |
雪印乳業株式会社 |
脂質の消化吸収機能改善剤
|
|
WO1999061581A2
(en)
|
1998-05-26 |
1999-12-02 |
Office Of The Dean Of Research And Graduate Education |
Sphingosine kinase, cloning, expression and methods of use
|
|
CA2362549A1
(en)
|
1999-02-24 |
2000-08-31 |
John Hopkins University |
Compositions and methods for modulating serum cholesterol
|
|
JP3544493B2
(ja)
|
1999-06-10 |
2004-07-21 |
雪印乳業株式会社 |
乳幼児用栄養組成物
|
|
KR100341793B1
(ko)
|
1999-07-02 |
2002-06-24 |
권 영 근 |
스핑고신 1-포스페이트를 유효성분으로 포함하는 혈관신생 촉진제
|
|
WO2001003739A1
(fr)
|
1999-07-12 |
2001-01-18 |
Ono Pharmaceutical Co., Ltd. |
Inhibiteurs de fibrose contenant comme ingredient actif l'agoniste du recepteur de sphingosine-1-phosphate ou la sphingosine-1-phosphate
|
|
JP2001213858A
(ja)
|
1999-11-24 |
2001-08-07 |
Sagami Chem Res Center |
スフィンゴシン誘導体
|
|
JP2001158736A
(ja)
|
1999-11-30 |
2001-06-12 |
Snow Brand Milk Prod Co Ltd |
骨関節疾患の予防及び改善剤
|
|
JP2001158735A
(ja)
|
1999-11-30 |
2001-06-12 |
Snow Brand Milk Prod Co Ltd |
歯周病の予防及び改善剤
|
|
AU784722B2
(en)
|
2000-02-18 |
2006-06-01 |
Merck & Co., Inc. |
Aryloxyacetic acids for diabetes and lipid disorders
|
|
WO2001072701A1
(en)
|
2000-03-28 |
2001-10-04 |
The Liposome Company, Inc. |
Ceramide derivatives and method of use
|
|
JP2002068998A
(ja)
|
2000-08-29 |
2002-03-08 |
Meiji Milk Prod Co Ltd |
経腸栄養および静脈栄養に伴う脂肪肝発生予防組成物
|
|
AU2001212597A1
(en)
|
2000-10-27 |
2002-05-06 |
N.V. Marc Boone |
Method for obtaining products enriched in phospho- and sphingolipids
|
|
US6949247B2
(en)
|
2000-12-28 |
2005-09-27 |
Unilever Home & Personal Care Usa Division Of Conopco, Inc. |
Stable skin care compositions containing a retinoid and a retinoid booster system
|
|
FR2820037B1
(fr)
*
|
2001-01-29 |
2005-12-09 |
Dermaconcept Jmc |
Composition dermatologique a usage veterinaire comprenant une base sphingoide
|
|
JP2002226394A
(ja)
|
2001-02-01 |
2002-08-14 |
Meiji Milk Prod Co Ltd |
脂質代謝改善組成物
|
|
DK1406641T3
(da)
|
2001-06-18 |
2009-05-04 |
Neptune Technologies & Bioress |
Krillekstrakter til forebyggelse og/eller behandling af cardiovaskulære sygdomme
|
|
CA2493888C
(en)
|
2001-07-27 |
2013-07-16 |
Neptune Technologies & Bioressources Inc. |
Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications
|
|
DE60117900D1
(de)
|
2001-09-05 |
2006-05-11 |
Charmzone Co |
Phytosphingosinderivate mit Antitumorwirkung
|
|
US20030109044A1
(en)
|
2001-10-16 |
2003-06-12 |
Millennium Pharmaceuticals, Inc. |
Methods of using 279, a human G protein-coupled protein receptor
|
|
JP4035759B2
(ja)
|
2001-11-06 |
2008-01-23 |
独立行政法人産業技術総合研究所 |
アミノアルコールリン酸化合物、製造方法、及びその利用方法
|
|
JP2003155231A
(ja)
*
|
2001-11-20 |
2003-05-27 |
Kikkoman Corp |
医薬及び抗アレルギー剤
|
|
JP2003252765A
(ja)
|
2002-02-28 |
2003-09-10 |
Snow Brand Milk Prod Co Ltd |
腸管運動機能不全性疾患の治療剤
|
|
DE10217555A1
(de)
|
2002-04-19 |
2004-02-19 |
Degussa Bioactives Deutschland Gmbh |
Physiologisch verträgliche, Phospholipid-haltige, stabile und harte Matrix
|
|
AU2003239489A1
(en)
|
2002-05-17 |
2003-12-02 |
Esperion Therapeutics, Inc. |
Method of treating dyslipidemic disorders
|
|
WO2004016257A1
(en)
|
2002-08-14 |
2004-02-26 |
Tae-Yoon Kim |
A composition comprising phytospingosine derivatives for apoptosis induction
|
|
EP1585508B1
(en)
|
2003-01-20 |
2009-04-01 |
Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO |
Use of sphingolipids for reducing plasma cholesterol and triacylglycerol levels
|
|
NL1022443C2
(nl)
|
2003-01-20 |
2004-07-22 |
Tno |
Sphingolipiden voor verbetering van de samenstelling van de darmflora.
|
|
GB0301395D0
(en)
|
2003-01-21 |
2003-02-19 |
Univ Aston |
Inflammatory disorder treatment
|
|
US20040171522A1
(en)
|
2003-02-27 |
2004-09-02 |
Yaron Ilan |
Regulation of immune responses by manipulation of intermediary metabolite levels
|
|
US9717754B2
(en)
|
2003-02-27 |
2017-08-01 |
Enzo Therapeutics, Inc. |
Glucocerebroside treatment of disease
|
|
WO2004096140A2
(en)
|
2003-04-25 |
2004-11-11 |
The Penn State Research Foundation |
Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
|
|
US8282773B2
(en)
|
2007-12-14 |
2012-10-09 |
Andritz Inc. |
Method and system to enhance fiber development by addition of treatment agent during mechanical pulping
|